269 related articles for article (PubMed ID: 21079309)
21. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
22. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
23. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
[TBL] [Abstract][Full Text] [Related]
25. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and its components in men.
Adriansjah H; Adam JM
Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
[TBL] [Abstract][Full Text] [Related]
27. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA; Victor TW
Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
[TBL] [Abstract][Full Text] [Related]
28. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
[TBL] [Abstract][Full Text] [Related]
29. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
[TBL] [Abstract][Full Text] [Related]
30. Comorbidities associated with psoriasis: an experience from the Middle East.
Al-Mutairi N; Al-Farag S; Al-Mutairi A; Al-Shiltawy M
J Dermatol; 2010 Feb; 37(2):146-55. PubMed ID: 20175849
[TBL] [Abstract][Full Text] [Related]
31. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.
Augustin M; Reich K; Glaeske G; Schaefer I; Radtke M
Acta Derm Venereol; 2010 Mar; 90(2):147-51. PubMed ID: 20169297
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of metabolic syndrome in Saudi adult soldiers.
Al-Qahtani DA; Imtiaz ML
Saudi Med J; 2005 Sep; 26(9):1360-6. PubMed ID: 16155648
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
34. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.
Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F
Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
37. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population.
Chedid R; Gannagé-Yared MH; Khalifé S; Halaby G; Zoghbi F
Metabolism; 2009 Jun; 58(6):746-52. PubMed ID: 19446111
[TBL] [Abstract][Full Text] [Related]
38. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.
Maloney EM; Boneva RS; Lin JM; Reeves WC
Metabolism; 2010 Sep; 59(9):1351-7. PubMed ID: 20102774
[TBL] [Abstract][Full Text] [Related]
39. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
[TBL] [Abstract][Full Text] [Related]
40. Chronic plaque psoriasis is associated with increased arterial stiffness.
Gisondi P; Fantin F; Del Giglio M; Valbusa F; Marino F; Zamboni M; Girolomoni G
Dermatology; 2009; 218(2):110-3. PubMed ID: 19060461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
